DealZone

Price per eyeball

April 7, 2008

jackie-chan.jpgUntil today, Portfolio.com’s Felix Salmon had no idea that there was a mega-billion dollar eye care company called Alcon — but when he pulls out his calculator he comes up with some interesting numbers:

“On a valuation level, let’s say that the population of the world is 6.6 billion, and let’s exclude the ‘bottom billion’ for the time being as people who are never going to avail themselves of Alcon’s products. That leaves 5.5 billion people, with 11 billion eyeballs between them. Which would mean that Alcon is valued at over $4 per global eyeball. Nice.”

For the record, Reuters reports that Novartis is buying Nestle’s 77 percent stake in Alcon for $39 billion — $11 billion up front, and $28 billion between January 2010 and July 2011 — which would imply a $50.64 billion total valuation, rather than the $45 billion figure Salmon uses.

The deal cost Novartis its triple-A credit rating, and loaded up Nestle’s acquisition war chest.

(Photo:  Reuters/Hong Kong movie star Jackie Chan plays with fake eyeball)

Post Your Comment

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/